39 / 64
243
57.- Seymour J F, Presneill J J. Pulmonary alveolar
proteinosis: progress in the first 44 years. Am J Respir
Crit Care Med 2002; 166: 215-35.
58.- Huizar I, Kavuru M S. Alveolar proteinosis syn-
drome: pathogenesis, diagnosis, and management. Curr
Opin Pulm Med 2009; 15: 491-8.
59.- Sverzellati N, Guerci L, Giorgia R, Ca-
labrò E, La Vecchia C, Marchianò A, et al.
Interstitial lung diseases in a lung cancer screening trial.
Eur Respir J 2011; 38: 392-400.
Correspondencia a:
Dr. Juan Carlos Rodríguez D.
Instituto Nacional del Tórax
Av. José M. Infante 717. Providencia.
Santiago de Chile.
Email:
jcerodriguez@gmail.com60.- Washko G R, Hunninghake G M, Fernán-
dez IE, Nishino M, OkajimaY, Yamashiro T,
et al. Lung volumes and emphysema in smokers with
interstitial lung abnormalities. N Engl J Med 2011; 364:
897-906.
61.- Jin G Y, Lynch D, Chawla A, Garg K, Tam-
memagi M C, Sahin H, et al. Interstitial lung ab-
normalities in a CT lung cancer screening population:
prevalence and progression rate. Radiology 2013; 268:
563-71.
Enfermedades pulmonares difusas relacionadas al tabaco
Rev Chil Enferm Respir 2016; 32: 233-243